Recommendation for caution with irinotecan, fluorouracil, leucovorin for colorectal cancer

被引：0
|
作者：
Klautke, G
Fietkau, R
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2002年 / 178卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [31] UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer
    Petrioli, R
    Sabatino, M
    Fiaschi, AI
    Marsilli, S
    Pozzessere, D
    Messinese, S
    Correalle, P
    Civitelli, S
    Tanzini, G
    Tani, F
    De Martino, A
    Marzocca, G
    Lorenzi, M
    Giorgi, G
    Francini, G
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 306 - 309
  • [32] Health-Related Quality of Life Impact of Bevacizumab When Combined with Irinotecan, 5-Fluorouracil, and Leucovorin or 5-Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
    Kabbinavar, Fairooz F.
    Wallace, Joel F.
    Holmgren, Eric
    Yi, Jing
    Cella, David
    Yost, Kathleen J.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2008, 13 (09): : 1021 - 1029
  • [33] Panitumumab therapy with irinotecan, 5-fluorouracil, and leucovorin (IFL) in patients (pts) with metastatic colorectal cancer (mCRC)
    Berlin, Jordan
    Malik, Imtiaz
    Picus, Joel
    Glisson, Shawn
    Kozloff, Mark
    Spitzer, Gary
    Wiens, Brian
    MacDonald, Monica
    Jerian, Susan
    Hecht, J. Randolph
    ANNALS OF ONCOLOGY, 2004, 15 : 70 - 71
  • [34] Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer
    Nozomu Fuse
    Toshihiko Doi
    Atsushi Ohtsu
    Tomonori Yano
    Yasuo Hamamoto
    Keiko Minashi
    Makoto Tahara
    Manabu Muto
    Masahiro Asaka
    Shigeaki Yoshida
    International Journal of Clinical Oncology, 2008, 13 : 144 - 149
  • [35] Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment
    Grothey, A
    Sargent, D
    Goldberg, RM
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1209 - 1214
  • [36] Multicenter phase II study of irinotecan plus bolus fluorouracil/l-leucovorin for metastasic colorectal cancer
    Mishima, Hideyuki
    Ikenaga, Masakazu
    Ishida, Hideyuki
    Iwamoto, Shigenori
    Morimoto, Takashi
    Narahara, Hiroyuki
    Kato, Takeshi
    Tsujie, Masaki
    Kitai, Toshiyuki
    Fukunaga, Mutsumi
    Nakanish, Masayoshi
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    Taguchi, Tetsuo
    ANTICANCER RESEARCH, 2007, 27 (02) : 1003 - 1008
  • [37] Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
    Carrato, Alfredo
    Swieboda-Sadlej, Anna
    Staszewska-Skurczynska, Marzanna
    Lim, Robert
    Roman, Laslo
    Shparyk, Yaroslav
    Bondarenko, Igor
    Jonker, Derek J.
    Sun, Yan
    De la Cruz, Jhony A.
    Williams, J. Andrew
    Korytowsky, Beata
    Christensen, James G.
    Lin, Xun
    Tursi, Jennifer M.
    Lechuga, Maria J.
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) : 1341 - 1347
  • [38] Safety of irinotecan and infusional fluorouracil/leucovorin (FOLFIRI) in Japan: a retrospective review of 48 patients with metastatic colorectal cancer
    Fuse, Nozomu
    Doi, Toshihiko
    Ohtsu, Atsushi
    Yano, Tomonori
    Hamamoto, Yasuo
    Minashi, Keiko
    Tahara, Makoto
    Muto, Manabu
    Asaka, Masahiro
    Yoshida, Shigeaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (02) : 144 - 149
  • [39] Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan
    Del Rio, Maguy
    Molina, Franck
    Mollevi, Caroline Bascoul
    Copois, Virginie
    Bibeau, Frederic
    Chalbos, Patrick
    Bareil, Corinne
    Kramar, Andrew
    Salvetat, Nicolas
    Fraslon, Caroline
    Conseiller, Emmanuel
    Granci, Virginie
    Leblanc, Benjamin
    Pau, Bernard
    Martineau, Pierre
    Ychou, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 773 - 780
  • [40] 5-fluorouracil plus calcium leucovorin and irinotecan in the treatment of metastatic colorectal cancer: Phase II study
    Salek, T.
    Mego, M.
    Mardiak, J.
    Porsok, S.
    Hlavata, Z.
    Dolinsky, J.
    Palacka, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 86
12345